RT Journal Article
SR Electronic
T1 586 Phase II study of Telomelysin (OBP-301) in combination with pembrolizumab in gastroesophageal (GEA) adenocarcinoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A666
OP A666
DO 10.1136/jitc-2023-SITC2023.0586
VO 11
IS Suppl 1
A1 Sarkar, Sandipto
A1 Khan, Sahrish
A1 Eads, Jennifer Rachel
A1 Sharaiha, Reem
A1 Carr-Locke, David
A1 Chang, Lillian
A1 Ginsberg, Gregory
A1 DiCicco, Lisa
A1 Garcia-Marcano, Luis
A1 Hissong, Erika
A1 Betel, Doron
A1 Shah, Manish
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A666.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.